Stock Events

Stock Events

Tscan Therapeutics (TCRX) Q1 2025 Earnings

5MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.32

-0.3

-0.27

-0.25

Details

Expected EPS

-0.31875

Actual EPS

-0.3

Surprise EPS

0.02

Surprise Percent

+5.88%

Description

Tscan Therapeutics (TCRX) has reported earnings of -0.3 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.